2-aminoperimidine has been researched along with 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime in 1 studies
| Studies (2-aminoperimidine) | Trials (2-aminoperimidine) | Recent Studies (post-2010) (2-aminoperimidine) | Studies (4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime) | Trials (4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime) | Recent Studies (post-2010) (4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime) |
|---|---|---|---|---|---|
| 11 | 0 | 4 | 13 | 0 | 10 |
| Protein | Taxonomy | 2-aminoperimidine (IC50) | 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | 3.2778 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 2.8 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 2.8 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 2.8 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 2.8 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 2.8 | |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 3.4 | |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | 4.5 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 2.8 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 2.8 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, M; Ambachew, B; Antonova-Koch, Y; Burrows, J; Calla, J; Campo, B; Chaumeau, V; Chen, K; Cheung, AL; Conway, AJ; Eribez, K; Fidock, DA; Gagaring, K; Gamo, FJ; Ibanez, M; Jado, JC; Kyle, DE; Lincoln, C; Llinás, M; Lukens, AK; Luth, MR; Maher, SP; McNamara, CW; Meister, S; Nosten, F; Ottilie, S; Owen, E; Plouffe, D; Rouillier, M; Sakata-Kato, T; Serrano, FN; Siegel, D; Taggard, CM; Vanaerschot, M; Winzeler, EA; Wirth, DF; Zhong, Y; Zhou, Y | 1 |
1 other study(ies) available for 2-aminoperimidine and 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime
| Article | Year |
|---|---|
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium | 2018 |